Skip to main content

MLEC · Moolec Science SA · Financials

Track MLEC — free
$2.20 -1.99 (-47.49%) At close · Oct 9
Market Cap
$1.60M
Shares
726,118
Volume · Oct 9 176.68K Avg daily vol (3M) 19.91K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$333.61M +5830.7%
FY2025 Revenue FY2023–FY2025
Net Income
-$111.46M -241%
FY2025 Net Income FY2023–FY2025
Gross Margin
39.02% +4905.5pp
FY2025 Gross Margin FY2023–FY2025
Operating Margin
-31.22% -374.1pp
FY2025 Operating Margin FY2023–FY2025
Diluted EPS
-$258.69 -207.2%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
$3.64M -90.8%
FY2025 Operating Cash Flow FY2022–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022
$333.61M $5.63M $905.05K —
$203.42M $279.37M $235.46M —
$130.19M -$273.74M -$234.56M —
39.02% -4866.44% -25916.72% —
$15.14M $17.42M $15.94M $985.16K
— $643.06K $256.42K $105.06K
$261.26K $696.76K $111.62K $2.52M
$6.02M $144.7K $23.4K $1699
-$104.15M $19.28M $98.05M -$3.65M
-31.22% 342.84% 10833.18% —
-$98.13M $19.43M $98.07M -$3.65M
— $1.17M $160.04K $2130
-$170M -$27.96M $50.79M -$4.53M
$6.64M $1.1M -$2.33M —
-$111.46M -$32.69M $40.44M -$4.53M
-33.41% -581.06% 4467.82% —
USD/shares -$258.69 -$84.22 $132.05 -$22.50
USD/shares -$258.69 -$84.22 $132.05 -$22.50
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2023–FY2025: $698.98K in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current debt instruments issued 2025-06-30 USD 58,000,000 20-F filed 2025-12-29
Current portion of long-term borrowings 2025-06-30 USD 227,154,007 20-F filed 2025-12-29
Lease liabilities 2025-06-30 USD 117,463 20-F filed 2025-12-29
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
USD 117,463
Loans received 2025-06-30 USD 10,000,000 20-F filed 2025-12-29
Noncurrent long-term borrowings 2025-06-30 USD 1,348,173 20-F filed 2025-12-29
Other borrowings 2025-06-30 USD 1,348,173 20-F filed 2025-12-29
Short-term borrowings 2025-06-30 USD 227,154,007 20-F filed 2025-12-29
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1937737 CUSIP G6223S125 Visit website Investor relations